Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.41 |
| ▸ | PPARG | P37231 | 3/20 | 0.41 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | RXRA | P19793 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.38 |
| ▸ | F7 | P08709 | 3/20 | 0.38 |
| ▸ | F3 | P13726 | 3/20 | 0.38 |
| ▸ | PPARA | Q07869 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | PPARD | Q03181 | 2/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.38 |
| ▸ | CNR1 | P21554 | 2/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4969578 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL1611678 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL1551787 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL17798928 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL10910041 | 1.00 | — | — | |
| SCHEMBL3387971 | 1.00 | — | — | |
| SCHEMBL21679678 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL21679677 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL21484057 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL21484058 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024117128-A1 | INTRAOCULAR PRESSURE LOWERING AGENT, AND AGENT FOR TREATING OR PREVENTING GLAUCOMA OR OCULAR HYPERTENSION | ＳＡＮＳＨＯ株式会社 | 2024-06-06 | — | — | WO | disclosed |
| US-20230108750-A1 | CARBALYSOPHOSPHATIDIC ACID | OCHANOMIZU UNIVERSITY (JP) | 2023-04-06 | — | — | US | disclosed |
| CN-115397846-A | Hydrophobic modified albumin and preparation method and application thereof | 昆山新蕴达生物科技有限公司 | 2022-11-25 | — | — | CN | disclosed |
| US-10413559-B2 | Method for treating demyelinating disease | OCHANOMIZU UNIVERSITY (JP) | 2019-09-17 | — | — | US | disclosed |
| EP-2949329-B1 | THERAPEUTIC AGENT FOR DEMYELINATING DISEASE | UNIV OCHANOMIZU (JP) | 2019-05-01 | — | — | EP | disclosed |
| US-20150352132-A1 | THERAPEUTIC AGENT FOR DEMYELINATING DISEASE | OCHANOMIZU UNIVERSITY (JP) | 2015-12-10 | — | — | US | disclosed |
| EP-2949329-A1 | THERAPEUTIC AGENT FOR DEMYELINATING DISEASE | Ochanomizu University (JP) | 2015-12-02 | — | — | EP | disclosed |
| EP-2098237-B1 | ANALGESIC AGENT COMPRISING CYCLIC PHOSPHATIDIC ACID DERIVATIVE | OCHANOMIZU UNIVERSITY (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-8017597-B2 | Analgesic agent comprising cyclic phosphatidic acid derivative | OCHANOMIZU UNIVERSITY (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20110086820-A1 | ANALGESIC AGENT COMPRISING CYCLIC PHOSPHATIDIC ACID DERIVATIVE | OCHANOMIZU UNIVERSITY (JP) | 2011-04-14 | — | — | US | disclosed |
| EP-1402894-B1 | CANCEROUS METASTASIS INHIBITORS CONTAINING CARBACYCLIC PHOSPHATIDIC ACID DERIVATIVES | MUROFUSHI KIMIKO (JP) | 2007-12-26 | — | — | EP | disclosed |
| US-20060122155-A1 | Carbacyclic phosphatidic acid derivative | SANSHO CO., LTD. (JP) | 2006-06-08 | — | — | US | disclosed |
| EP-1535926-A1 | CARBACYCLIC PHOSPHATIDIC ACID DERIVATIVE | Murofushi, Kimiko (JP) | 2005-06-01 | — | — | EP | disclosed |
| US-20040220149-A1 | Nerve cell survival promoters containing cyclic phosphatidic acid derivative | GENCOM CORPORATION (JP) | 2004-11-04 | — | — | US | disclosed |
| US-20040176329-A1 | Drugs for promoting the proliferation, differentiation and/or survival of glial cells containing cyclic phosphatidic acid | KIMIKO MUROFUSHI (JP) | 2004-09-09 | — | — | US | disclosed |
| US-6750332-B1 | HAVE VALUABLE COSMETICALLY AND PHARMACEUTICALLY USEFUL PROPERTIES, SUCH AS PROSTAGLANDIN SYNTHESIS INHIBITION; SALICIN ESTERS | COGNIS DEUTSCHLAND GMBH & CO. KG (DE) | 2004-06-15 | — | — | US | disclosed |
| EP-1402894-A1 | CANCEROUS METASTASIS INHIBITORS CONTAINING CARBACYCLIC PHOSPHATIDIC ACID DERIVATIVES | Gencom Corporation (JP) | 2004-03-31 | — | — | EP | disclosed |
| EP-1391204-A1 | NERVE CELL SURVIVAL PROMOTERS CONTAINING CYCLIC PHOSPHATIDIC ACID DERIVATIVE | Gencom Corporation (JP) | 2004-02-25 | — | — | EP | disclosed |
| EP-1386612-A1 | DRUGS FO RPROMOTING THE PROLIFERATION, DIFFERENTIATION AND/OR SURVIVAL OF GLIAL CELLS CONTAINING CYCLIC PHOSPHATIDIC ACID | Gencom Corporation (JP) | 2004-02-04 | — | — | EP | disclosed |
| WO-2000068239-A1 | NOVEL SALICYL ALCOHOL DERIVATIVES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-11-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230108750-A1 | CARBALYSOPHOSPHATIDIC ACID | PHOSPHO1, SGMS1, PLD1 | ALDH1A1 3690/4885CYP19A1 2535/4885PPARG 1990/4885 |
| US-20040176329-A1 | Drugs for promoting the proliferation, differentiation and/or survival of glial cells containing cyclic phosphatidic acid | GAP43, SMPD2, SMPD3 | ALDH1A1 3248/4885CYP19A1 3519/4885PPARG 427/4885 |
| US-20150352132-A1 | THERAPEUTIC AGENT FOR DEMYELINATING DISEASE | PMP22, MAG, SGMS1 | ALDH1A1 3983/4885CYP19A1 4850/4885PPARG 1821/4885 |
| US-20060122155-A1 | Carbacyclic phosphatidic acid derivative | SGMS1, SGMS2, LPAR2 | ALDH1A1 3742/4885CYP19A1 1664/4885PPARG 949/4885 |
| US-10413559-B2 | Method for treating demyelinating disease | PMP22, MAG, SGMS1 | ALDH1A1 3689/4885CYP19A1 4694/4885PPARG 1408/4885 |
| US-20040220149-A1 | Nerve cell survival promoters containing cyclic phosphatidic acid derivative | NGF, GAP43, PLA2G4A | ALDH1A1 3386/4885CYP19A1 4573/4885PPARG 2331/4885 |
| US-20110086820-A1 | ANALGESIC AGENT COMPRISING CYCLIC PHOSPHATIDIC ACID DERIVATIVE | PLA2G4A, PLA2G6, PLA2G2A | ALDH1A1 1618/4885CYP19A1 1890/4885PPARG 1808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.